RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 16 - per page Next page
Order by
25 and 50 mg diclofenac K film coated immediate release tablets More
Topical Diclofenac formulations for the treatment of inflammatory and painful conditions More
Fentanyl patch for the management of severe pain in patients who require continuous opioid analgesia. More
Adhesive Patch of 90 sq. cm. and containing as active ingredient 100 mg. of ketoprofen for the local treatment of traumatic injuries and extra-articular rheumatism More
25mg dosage strenght for the OTC market in film coated tablets More
The First Line of Therapy in Severe Migraine Attacks More
12,5 mg diclofenac K film coated immediate release tablets (OTC) More
The first pure, immediate release (Tmax in 13,68 min), completely palatable and free from aftertaste diclofenac potassium formulation in drops at 5% available on the market More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Displaying 1..10 of 16 - per page Next page
Order by

Related Reports

Your selection

Therapeutic target
Central Nervous System del
Pain del
Pain, inflammatory del

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2014 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us